Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Human tissue mast cells are an inducible reservoir of persistent HIV infection.

Sundstrom JB, Ellis JE, Hair GA, Kirshenbaum AS, Metcalfe DD, Yi H, Cardona AC, Lindsay MK, Ansari AA.

Blood. 2007 Jun 15;109(12):5293-300. Epub 2007 Mar 9.

2.

IgE-FcepsilonRI interactions determine HIV coreceptor usage and susceptibility to infection during ontogeny of mast cells.

Sundstrom JB, Hair GA, Ansari AA, Secor WE, Gilfillan AM, Metcalfe DD, Kirshenbaum AS.

J Immunol. 2009 May 15;182(10):6401-9. doi: 10.4049/jimmunol.0801481.

3.

Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells.

Sundstrom JB, Little DM, Villinger F, Ellis JE, Ansari AA.

J Immunol. 2004 Apr 1;172(7):4391-401.

4.

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.

J Infect Dis. 2009 Nov 15;200(10):1490-7. doi: 10.1086/644598.

PMID:
19832114
5.

Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy.

Guibert G, Warszawski J, Le Chenadec J, Blanche S, Benmebarek Y, Mandelbrot L, Tubiana R, Rouzioux C, Leruez-Ville M; French Perinatal Cohort.

Clin Infect Dis. 2009 Jun 1;48(11):1516-25. doi: 10.1086/598934.

PMID:
19388872
6.

Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART).

Bansil P, Jamieson DJ, Posner SF, Kourtis AP.

J Womens Health (Larchmt). 2007 Mar;16(2):159-62.

PMID:
17388731
7.

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16. doi: 10.1097/QAI.0b013e3181b323ff.

PMID:
19730269
8.

Production of the HIV-suppressive chemokines CCL3/MIP-1alpha and CCL22/MDC is associated with more effective antiretroviral therapy in HIV-infected children.

Lambert JS, Machado ES, Watson DC, Sill AM, Lim JK, Charurat M, Cunha SM, Afonso AO, Oliviera RH, Tanuri A, DeVico AL.

Pediatr Infect Dis J. 2007 Oct;26(10):935-44.

PMID:
17901800
9.

Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.

Twigg Iii HL, Weiden M, Valentine F, Schnizlein-Bick CT, Bassett R, Zheng L, Wheat J, Day RB, Rominger H, Collman RG, Fox L, Brizz B, Dragavon J, Coombs RW, Bucy RP; AIDS Clinical Trials Group Protocol 723 Team.

J Infect Dis. 2008 Jan 1;197(1):109-16. doi: 10.1086/523766.

PMID:
18171293
10.

Human Mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro.

Bannert N, Farzan M, Friend DS, Ochi H, Price KS, Sodroski J, Boyce JA.

J Virol. 2001 Nov;75(22):10808-14.

11.
12.

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524.

PMID:
18199042
13.

Immunologic features of HIV-1-infected women on HAART at delivery.

Ono E, Dos Santos AM, Machado DM, Succi RC, Amed AM, Salomão R, Kallás EG, de Moraes-Pinto MI.

Cytometry B Clin Cytom. 2008 Jul;74(4):236-43. doi: 10.1002/cyto.b.20418.

14.

Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.

Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M.

J Virol. 2007 Sep;81(18):9693-706. Epub 2007 Jul 3.

15.

HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection.

Garrido M, Mozos A, Martínez A, García F, Serafín A, Morente V, Caballero M, Gil C, Fumero E, Miró JM, Climent N, Gatell JM, Alos L.

J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):268-74.

PMID:
17786132
16.

Hematopoietic stem/precursor cells as HIV reservoirs.

McNamara LA, Collins KL.

Curr Opin HIV AIDS. 2011 Jan;6(1):43-8. doi: 10.1097/COH.0b013e32834086b3. Review.

17.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
18.

Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.

Laurichesse JJ, Persoz A, Theodorou I, Rouzioux C, Delfraissy JF, Meyer L.

HIV Med. 2007 May;8(4):213-9.

19.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
20.

Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.

Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR.

J Infect Dis. 2007 Oct 1;196(7):1044-52. Epub 2007 Aug 29.

PMID:
17763327

Supplemental Content

Support Center